Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd. share price is ₹662.40 as of November 30, 2023, 09:57 AM. Share prices change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

Market cap is calculated by multiplying the company's share price with the total outstanding shares. The market cap of Lincoln Pharmaceuticals Ltd. is ₹1,327 Cr as of November 30, 2023.

The PE ratio of Lincoln Pharmaceuticals Ltd. is 16.40 as of November 30, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).

The trailing twelve month (TTM) PB ratio of Lincoln Pharmaceuticals Ltd. is 2.60 as of November 30, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

Upper Circuit is ₹794.85. Lower Circuit is ₹529.95.

Lincoln Pharmaceuticals Ltd. reported an ROE of 14.50% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Lincoln Pharmaceuticals Ltd., Promoter held 50.5%, the FII held 2.6%, and the public held 46.9% of the total shares.

You can easily buy shares of Lincoln Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

Fair value in investing refers to the estimated potential price of the business. The market (or exchange) is expected to determine the fair value of listed companies by the way of demand and supply. To determine the fair value of Lincoln Pharmaceuticals Ltd. as per market, look at the current bid and ask prices during the trading hours.